193 completed. 193 Phase 2, 23 Phase 3, 15 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 193 | Completed 193 |
| Phase 3 | 23 | Completed 23 |
| Phase 1 | 15 | Completed 15 |
Follow Sugars: new trials by email Literature Review of Sugars trials Research Report on Sugars
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of LAU-7b for the Treatment of Long COVID in Adults LAU-7b for 3 cycles, LAU-7b for 1 cycle, then placebo, Placebo for 3 cycles - Long COVID | Phase 2 / Phase 3 | Completed | Laurent Pharmaceuticals Inc. | 272 | 2023-11-15 | 2026-01-06 |
| A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID. Nirmatrelvir, Ritonavir, Placebo - Long COVID | Phase 2 | Completed | Harlan M Krumholz | 100 | 2023-04-14 | 2024-12-02 |
| Effects of Quetiapine on Sleep and Next Day Alertness in People With Obstructive Sleep Apnea Quetiapine 50 MG, Placebo - Sleep Apnea, Obstructive | Phase 2 | Completed | Flinders University | 15 | 2022-05-25 | 2023-07-06 |
| Medication Development in Alcoholism: Suvorexant Versus Placebo Suvorexant 20 mg, Placebo oral tablet - Alcohol Use Disorder (AUD) | Phase 2 | Completed | The Scripps Research Institute | 26 | 2021-11-17 | 2023-04-26 |
| Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo Miricorilant, Placebo oral tablet - Alcohol Use Disorder | Phase 2 | Completed | The Scripps Research Institute | 50 | 2021-04-15 | 2023-02-03 |
| Gabapentin and Tizanidine for Insomnia in Chronic Pain Gabapentin, Placebo, Tizanidine - Insomnia Due to Medical Condition, Chronic Pain | Phase 2 | Completed | University of California, San Diego | 9 | 2020-07-29 | 2025-01-03 |
| Neurobiology of Bulimia Nervosa Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa | Phase 2 | Completed | University of North Carolina, Chapel Hill | 10 | 2020-02-24 | 2022-07-26 |
| UH3 Varenicline for Cannabis Use Disorder Varenicline, Placebo - Cannabis Use Disorder | Phase 2 | Completed | Medical University of South Carolina | 174 | 2020-01-31 | 2024-01-18 |
| A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa Serlopitant Tablet, Placebo Oral Tablet - Epidermolysis Bullosa | Phase 2 | Completed | Stanford University | 28 | 2019-04-18 | 2023-02-14 |
| Effect of Melatonin on Reduction of Pelvic Pain Melatonin 10 mg, Placebo, Melatonin 20 mg - Dysmenorrhea, Endometriosis | Phase 2 | Completed | Karolinska Institutet | 80 | 2019-03-15 | 2022-04-05 |
| Fluoxetine Opens Window to Improve Motor Recovery After Stroke Fluoxetine Hydrochloride, Placebo, Exercise Program - Stroke, Cerebrovascular Accident | Phase 2 | Completed | University Health Network, Toronto | 52 | 2019-01-01 | 2022-11-04 |
| Therapy in Amyotrophic Lateral Sclerosis (TAME) Memantine, Placebo (for Memantine) - Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia | Phase 2 | Completed | University of Kansas Medical Center | 89 | 2018-11-07 | 2022-11-29 |
| Enhancing Self Regulation Among Smokers sirolimus, Placebo - Smoking Cessation, Smoking, Cigarette | Phase 2 | Completed | Medical University of South Carolina | 22 | 2018-10-01 | 2021-03-09 |
| Ibudilast for the Treatment of Alcohol Use Disorder Ibudilast, Placebo oral capsule - Alcohol Use Disorder | Phase 2 | Completed | University of California, Los Angeles | 102 | 2018-10-01 | 2024-11-27 |
| Medication Development in Alcoholism: Apremilast Versus Placebo Apremilast, Placebo - Alcohol Use Disorder | Phase 2 | Completed | The Scripps Research Institute | 51 | 2017-11-01 | 2022-09-16 |
| Effect of Galantamine on Inflammation and Cognition Galantamine, Placebo - HIV Associated Cognitive Motor Complex | Phase 2 | Completed | University of Pennsylvania | 63 | 2017-10-30 | 2024-10-17 |
| The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension Trimetazidine, Placebo oral capsule - Precapillary Pulmonary Hypertension | Phase 2 / Phase 3 | Completed | Universitas Indonesia | 26 | 2017-09-10 | 2019-10-03 |
| Buproprion for Binge Drinking Bupropion, Placebo Oral Tablet - Alcohol Abuse | Phase 2 | Completed | University of North Carolina, Chapel Hill | 42 | 2017-09-04 | 2020-08-26 |
| Aspirin in Young Psychotic Patients Aspirin, Placebo, Pantoprazole - Psychosis, Acute Psychosis | Phase 2 / Phase 3 | Completed | Clinic for Psychiatric Disorders, Dr Laza Lazarevic | 60 | 2017-07-20 | 2024-09-23 |
| Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD) Guanfacine XR 3mgs/daily, Placebo (for guanfacine) - Alcohol Abstinence | Phase 1 / Phase 2 | Completed | Stony Brook University | 32 | 2017-07-12 | 2024-06-05 |
Showing 20 of 193. Sign in to see all of them.
Alcoholism (21) · Tobacco Use Disorder (8) · Breast Neoplasms (6) · Substance-Related Disorders (6) · Behavior, Addictive (5) · Pain (5) · Recurrence (5) · cyclopia sequence (5) · Cocaine-Related Disorders (4) · Marijuana Abuse (4) · Schizophrenia (4) · Sleep Initiation and Maintenance Disorders (4) · Alzheimer Disease (3) · Amyotrophic Lateral Sclerosis (3) · Attention Deficit Disorder with Hyperactivity (3)
University of California, Los Angeles (9) · University of North Carolina, Chapel Hill (8) · M.D. Anderson Cancer Center (7) · The Scripps Research Institute (6) · University of Minnesota (6) · University of Pennsylvania (6) · Medical University of South Carolina (5) · University of Chicago (5) · Johns Hopkins University (4) · Mayo Clinic (4) · Milton S. Hershey Medical Center (4) · Stanford University (4) · Duke University (3) · VA Office of Research and Development (3) · XenoPort, Inc. (3)
United States (160) · Canada (7) · United Kingdom (6) · Germany (5) · Israel (4) · Italy (4) · Spain (4) · Australia (3) · Bulgaria (3) · Poland (3) · Sweden (3) · Czechia (2) · South Africa (2) · Austria (1) · Belgium (1)
Barbara J. Mason, Ph.D. (4) · Aaron S Kelly, Ph.D. (2) · Gary B. Gunn, MD (2) · Jay Huff, M.D. (2) · Jon E Grant, JD, MD, MPH (2) · Jon E Grant, MD, JD, MPH (2) · Lara Ray, PhD (2) · Rebecca Ashare, Ph.D. (2) · Steven Shoptaw, PhD (2) · Aaron S. Kelly, Ph.D. (1) · Adrian Hernandez, MD (1) · Aikaterini A Bouzia, Medicine (1) · Aimee L McRae, PharmD (1) · Aimee McRae-Clark, PharmD (1)
PMID 37142273, PMID 36130734, PMID 15692967, PMID 16790698, PMID 17469162, PMID 17485423, PMID 17717203, PMID 17901414, PMID 18174456, PMID 18641099, PMID 19155011, PMID 19489872, PMID 19776222, PMID 19892673, PMID 20092966, PMID 20466589, PMID 20580029, PMID 20638463, PMID 20740615, PMID 21144505, PMID 21161651, PMID 21380937, PMID 21419606, PMID 21467190, PMID 21632810, PMID 21677329, PMID 21849262, PMID 22217949, PMID 22324516, PMID 22445683, PMID 22984171, PMID 23044556, PMID 23188075, PMID 23380890, PMID 23444220, PMID 23507358, PMID 23562364, PMID 23586456, PMID 23744513, PMID 23751236, PMID 23782126, PMID 23925396, PMID 24345329, PMID 24399554, PMID 24852376, PMID 24950747, PMID 24986712, PMID 25129340, PMID 25452309, PMID 25602175
R01AA012602 (3), P50DA018185 (2), R01CA026582 (2), 1RC1DA028279-01 (1), 1UL1RR029876-01 (1), 2008 (1), 2009 (1), 2015 (1), 3UL1RR025005 (1), K07CA168886 (1), K23DA035295 (1), M01RR000073 (1), P01CA124787 (1), P30CA138292 (1), P50DK083007 (1)